T. Rowe Price Investment Management Reports 8.3% Stake in QuidelOrtho Corp (QDEL)

T. Rowe Price Investment Management, Inc. has filed a Schedule 13G/A (Amendment No. 5) with the SEC, reporting a significant stake in QuidelOrtho Corp (QDEL). As of the event date on March 31, 2026, the investment management firm disclosed beneficial ownership of 5,629,965 shares of common stock, representing an 8.3% ownership stake in the company. The filing indicates that T. Rowe Price Investment Management, Inc. maintains sole dispositive power over all 5,629,965 shares and sole voting power over 5,612,705 shares. This filing represents an increase in holdings compared to previous reports where the ownership percentage was not as high. The securities were acquired in the ordinary course of business, and the filer certified that the acquisition was not intended to influence or change the control of the issuer. T. Rowe Price Investment Management, Inc. is a Maryland-based investment adviser. The total value of the position is estimated at approximately $84.34 million based on recent market data.